News and Trends 27 Jun 2023
Astraveus exits stealth to advance cell and gene therapy platform
Astraveus SAS has emerged from stealth with the completion of an oversubscribed €16.5 million ($18.1 million) Series Seed financing. The company creates modular, microfluidic cell foundries that transform cell and…